Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries-Reference-Cited by-同舟云学术

Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries

Published:2022-02 Issue:2 Volume:9 Page:113-124
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Arango Celso,Buitelaar Jan K,Fegert Jörg M,Olivier Valérie,Pénélaud Pierre-François,Marx Ute,Chimits Damien,Falissard Bruno,Barylnik Julia,Birdeanu Laura,Bosch Gert P,Boychevskaya Julia,Boyev Igor,Bugán Enikõ,Bukhanovskaya Olga,Chaban Oleg,Dobrescu Iuliana,Feller Gábor,Flisiak-Antonijczuk Halina,Gácser Magdolna,Grigorieva Elena,Holttinen Timo,Ivanovic-Kovacevic Svetlana,Kapornai Krisztina,Kasimova Lala,Martsenkovsky Igor,Maruta Nataliya O,Matican Mirela,Matkovska Tetiana,Melnyk Ellina,Milovancevic Milica Pejovic,Mostova Olha,Nagy Peter,Nussbaum Laura,Petrov Petar,Pietraszczyk-Kedziora Bozena,Polnareva Nadia,Predescu Elena,Razsolkova Vladislava,Rybakowski Filip,Rymsha Sofiia,Schrönen Juan P,Shigashov Dmitrii,Skrypnikov Andrii,Stankovic Miodrag,Stevanovic Dejan,Timonen Markku,Väänänen Juha-Matti,van der Westhuizen Jannie,van Niekerk Gert,Venger Olena,Vladimirovich Evgeniy,Voloshchuk Anatolii,Wolańczyk Tomasz

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference27 articles.

1. Treatment of major depressive disorder in pediatric populations;Neavin;Diseases,2018

2. Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES;Merikangas;Pediatrics,2010

3. Phenomenology of major depression from childhood through adulthood: analysis of three studies;Carlson;Am J Psychiatry,1988

4. Phenomenology of depression in children and adolescents;Mitchell;J Am Acad Child Adolesc Psychiatry,1988

5. Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder;Yorbik;J Clin Psychiatry,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studies;European Child & Adolescent Psychiatry;2024-09-06

2. Advances in biosensors for major depressive disorder diagnostic biomarkers;Biosensors and Bioelectronics;2024-08

3. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis;BMC Psychiatry;2023-11-24

4. The place of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents. Recommendations of the Main Board of the Polish Psychiatric Association. Part 1 - Clinical efficacy and areas of application;Psychiatria Polska;2023-10-31

5. Changes of Serum C-Reactive Protein Level in Patients With Depressive Disorders After Treatment With Agomelatine Combined With Aerobic Exercise and Its Significance;Clinical Neuropharmacology;2023-09